MTNB - Matinas BioPharma Holdings, Inc.
0.5282
-0.007 -1.287%
Share volume: 2,764
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$0.54
-0.01
-0.01%
Summary score
16%
Profitability
0%
Dept financing
6%
Liquidity
75%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.97%
Return on assets
-12.95%
Return on sales
-5341%
Return on invested capital
-89.14%
Total debt ratio
15.26%
Debt ratio change over timeo
-1.18%
Current Ratio
13.57%
Quick Ratio
13.06%
Cash Position Ratio
11.45%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25.17%
Return on assets
-20.73%
Return on sales
0%
Return on invested capital
-83.4%
Total debt ratio
21.77%
Debt ratio change over timeo
-1.27%
Current Ratio
6.73%
Quick Ratio
7.13%
Cash Position Ratio
6.11%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-20.78%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
23.32%
Debt ratio change over time
-1.3%
Current Ratio
5.53%
Quick Ratio
0%
Cash Position Ratio
4.85%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.44%
Return on assets
-84.51%
Return on sales
6029.52%
Return on invested capital
3.74%
Total debt ratio
-118.37%
Debt ratio change over time
-1.18%
Current Ratio
-16.73%
Quick Ratio
-15.48%
Cash Position Ratio
-13.83%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MTNB | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -13.97% | 18.83% | 17.34% | 0% |
| Return on assets | -12.95% | 4.14% | 8.21% | 0% |
| Return on sales | -5341% | 27.93% | 41.18% | 0% |
| Return on invested capital | -89.14% | 9.79% | -219.55% | 0% |
| Profitability | 0% | 80% | 73% | 0% |
| Total debt ratio | 15.26% | 82.52% | 55.88% | 0% |
| Debt ratio change over time | -1.18% | -13.08% | -0.73% | 0% |
| Dept financing | 5% | 25% | 17% | 25% |
| Current Ratio | 6.73% | 1.13% | 0% | 0% |
| Quick Ratio | 7.13% | 0.87% | 0% | 0% |
| Cash Position Ratio | 6.11% | 0.12% | 0% | 0% |
| Liquididy | 75% | 4% | 4% | 0% |
| Short-term ratios | MTNB | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -25.17% | 13.31% | 0% | 0% |
| Return on assets | -20.73% | 4.46% | 0% | 0% |
| Return on sales | 0% | 29.96% | 0% | 0% |
| Return on invested capital | -83.4% | 10.68% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 21.77% | 81.12% | 0% | 0% |
| Debt ratio change over time | -1.27% | -58.72% | 0% | 0% |
| Dept financing | 7% | 25% | 25% | 0% |
| Current Ratio | 6.73% | 1.13% | 0% | 0% |
| Quick Ratio | 7.13% | 0.87% | 0% | 0% |
| Cash Position Ratio | 6.11% | 0.12% | 0% | 0% |
| Liquididy | 75% | 8% | 0% | 0% |